Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Jilaveanu LB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mann JE; Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA., Hasson N; Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA., Su DG; Division of Surgical Oncology, Yale University School of Medicine, New Haven, CT, USA., Adeniran AJ; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Smalley KSM; Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Djureinovic D; Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA., Jilaveanu LB; Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA., Schoenfeld DA; Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA., Kluger HM; Division of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. Harriet.kluger@yale.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Aug 06; Vol. 73 (10), pp. 191. Date of Electronic Publication: 2024 Aug 06.
Autor:
Provance OK; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Oria VO; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark., Tran TT; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Caulfield JI; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Zito CR; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA.; Department of Biology, School of Arts, Sciences, Business, and Education, University of Saint Joseph, West Hartford, CT, USA., Aguirre-Ducler A; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Schalper KA; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Kluger HM; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Jilaveanu LB; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA. lucia.jilaveanu@yale.edu.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Apr 18; Vol. 81 (1), pp. 188. Date of Electronic Publication: 2024 Apr 18.
Autor:
Djureinovic D; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Weiss SA; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Krykbaeva I; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Qu R; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Vathiotis I; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Moutafi M; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Zhang L; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Perdigoto AL; Department of Internal Medicine, Yale University, New Haven, CT, USA., Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA., Anderson G; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Damsky W; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA., Hurwitz M; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Johnson B; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Schoenfeld D; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Mahajan A; Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA., Hsu F; Apexigen, Inc., San Carlos, CA, USA., Miller-Jensen K; Department of Biomedical Engineering, Yale University, New Haven, CT, USA.; Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.; Systems Biology Institute, Yale University, New Haven, CT, USA., Kluger Y; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Sznol M; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute, La Jolla, CA, USA., Bosenberg M; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Jilaveanu LB; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Kluger HM; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA. Harriet.Kluger@yale.edu.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 Nov 14; Vol. 22 (1), pp. 182. Date of Electronic Publication: 2023 Nov 14.
Autor:
Tran TT; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Caulfield J; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Zhang L; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Schoenfeld D; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Djureinovic D; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Chiang VL; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.; Yale School of Medicine, Department of Neurosurgery, New Haven, Connecticut, USA., Oria V; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Weiss SA; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Olino K; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.; Yale School of Medicine, Department of Surgery, New Haven, Connecticut, USA., Jilaveanu LB; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA., Kluger HM; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
Publikováno v:
JCI insight [JCI Insight] 2023 Apr 10; Vol. 8 (7). Date of Electronic Publication: 2023 Apr 10.
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma.
Autor:
Oria VO; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA.; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark., Zhang H; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA.; Department of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, Guangdong, China., Zito CR; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA.; Department of Biology, School of Arts, Sciences, Business, and Education, University of Saint Joseph, West Hartford, CT, USA., Rane CK; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Ma XY; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Provance OK; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Tran TT; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Adeniran A; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Kluger Y; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Sznol M; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Bosenberg MW; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA., Kluger HM; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA., Jilaveanu LB; Section of Medical Oncology, Department of Medicine, Yale University School of Medicine, 333 Cedar Street, SHM234E, New Haven, CT, 06520, USA. lucia.jilaveanu@yale.edu.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2022 Jun 23; Vol. 79 (7), pp. 377. Date of Electronic Publication: 2022 Jun 23.
Autor:
Guo X; Department of Medicine Section of Nephrology, Yale University, New Haven, CT, USA., Jessel S; Department of Medicine Section of Medical Oncology, Yale University, New Haven, CT, USA., Qu R; Department of Medicine Pathology, Yale University, New Haven, CT, USA., Kluger Y; Department of Medicine Pathology, Yale University, New Haven, CT, USA., Chen TM; Department of Medicine Section of Nephrology, Yale University, New Haven, CT, USA., Hollander L; Department of Medicine Section of Nephrology, Yale University, New Haven, CT, USA., Safirstein R; Department of Medicine Section of Nephrology, Yale University, New Haven, CT, USA; Department of Medicine VACHS, Yale University, New Haven, CT, USA., Nelson B; Department of Medicine Pharmacology, Yale University, New Haven, CT, USA., Cha C; Department of Medicine Surgery, Yale University, New Haven, CT, USA., Bosenberg M; Department of Medicine Section of Medical Oncology, Yale University, New Haven, CT, USA., Jilaveanu LB; Department of Medicine Section of Medical Oncology, Yale University, New Haven, CT, USA., Rimm D; Department of Medicine Pathology, Yale University, New Haven, CT, USA., Rothlin CV; Department of Medicine Immunology, Yale University, New Haven, CT, USA., Kluger HM; Department of Medicine Section of Medical Oncology, Yale University, New Haven, CT, USA., Desir GV; Department of Medicine Section of Nephrology, Yale University, New Haven, CT, USA; Department of Medicine VACHS, Yale University, New Haven, CT, USA; Department of Medicine Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: gary.desir@yale.edu.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Apr; Vol. 165, pp. 81-96. Date of Electronic Publication: 2022 Feb 24.
Autor:
Lu BY; Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut, USA., Gupta R; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Aguirre-Ducler A; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Gianino N; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Wyatt H; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Ribeiro M; Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut, USA., Chiang VL; Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA., Contessa JN; Radiation Oncology, Yale School of Medicine, New Haven, Connecticut, USA.; Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA., Adeniran AJ; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Jilaveanu LB; Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut, USA., Kluger HM; Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut, USA., Schalper KA; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Goldberg SB; Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut, USA sarah.goldberg@yale.edu.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Oct; Vol. 9 (10).
Autor:
Zhang SM; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Cai WL; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Liu X; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Thakral D; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Luo J; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center, Yale School of Medicine, New Haven, CT, USA.; Yale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA., Chan LH; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., McGeary MK; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Song E; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Blenman KRM; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.; Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Micevic G; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Jessel S; Department of Medicine, Yale School of Medicine, New Haven, CT, USA., Zhang Y; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China., Yin M; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China., Booth CJ; Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA., Jilaveanu LB; Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Damsky W; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Sznol M; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Kluger HM; Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Yale Center for Immuno-Oncology, Yale School of Medicine, New Haven, CT, USA., Iwasaki A; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Yale Center for Immuno-Oncology, Yale School of Medicine, New Haven, CT, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Bosenberg MW; Department of Pathology, Yale School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.; Yale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu.; Yale Center for Immuno-Oncology, Yale School of Medicine, New Haven, CT, USA. marcus.bosenberg@yale.edu., Yan Q; Department of Pathology, Yale School of Medicine, New Haven, CT, USA. qin.yan@yale.edu.; Yale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA. qin.yan@yale.edu.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. qin.yan@yale.edu.; Yale Center for Immuno-Oncology, Yale School of Medicine, New Haven, CT, USA. qin.yan@yale.edu.
Publikováno v:
Nature [Nature] 2021 Oct; Vol. 598 (7882), pp. 682-687. Date of Electronic Publication: 2021 Oct 20.